FDA panel says no to over-the-counter statin drugs; will the recommendation stand?

After all, NSAIDs (pain killers) are sold as over-the-counter drugs, and new research has shown that NSAIDs cause intestinal damage in as many as 70% of all users, outright killing an estimated 16,500 Americans each year from gastrointestinal bleeding. What's another few thousand deaths from statin drugs, after all? We're talking PROFITS here! Gotta keep those shareholders happy!

Fortunately, a moment of sanity has mysteriously emerged at the Food and Drug Administration, whose advisory panel has voted against allowing statin drugs to be sold without a prescription. Where did this sanity come from? Probably from all the recent drug scandals in which the FDA has been caught with its pants around its ankles... the Vioxx scandal, namely. Plus, there's the FOIA document that surfaced, showing that two-thirds of the FDA's own scientists don't think the agency can protect the safety of Americans, and nearly 1/5th of FDA scientists say they have been pressured to approve a drug they thought was unsafe.

In light of the recent drug safety scrutiny, the FDA is treading lightly. But don't worry, as soon as all this scrutiny blows over, they'll get right back to rubber-stamping dangerous drugs and padding the profits of Big Pharma. That is, if serious FDA reform doesn't dismantle the agency first.

Keep in mind that Merck and J&J can just reapply again next year. And the year after. And technically, the FDA doesn't have to listen to the advisory panel in the first place. They can just stamp "Approved!" on the drug, regardless of what the panel recommendations are.

But for today, consumers are just a little bit safer with statin drugs not being allowed as over-the-counter medications. Whether we actually have the FDA to thank for this is difficult to tell. Frankly, Dr. David Graham deserves most of the thanks here: without his warnings, the FDA wouldn't be under such scrutiny in the first place, and the OTC application for these statin drugs probably would have sailed through without a peep.

After all, NSAIDs are still legal, and they kill five times as many people each year as all the terrorist-related deaths ever recorded on American soil. If NSAIDs were, say, a Chinese herb, they would have been banned long ago, and armed FDA agents would have raided all the stores carrying inventory in order to "protect Americans." But NSAIDs remain legal for one reason only: they're profitable.

As I've said before, if all the people who died from over-the-counter drugs in America were to rise from their graves and march on Washington, the demand for change would be unstoppable. But dead people don't march, and they can't tell you, "Oh by the way, I was actually killed by over-the-counter drugs."

###

About the author: Mike Adams is a natural health author and technology pioneer with a strong interest in personal health, the environment and the power of nature to help us all heal He has authored and published thousands of articles, interviews, consumers guides, and books on topics like health and the environment, reaching millions of readers with information that is saving lives and improving personal health around the world. Adams is a trusted, independent journalist who receives no money or promotional fees whatsoever to write about other companies' products. In 2007, Adams launched EcoLEDs, a maker of energy efficient LED lights that greatly reduce CO2 emissions. He also founded an environmentally-friendly online retailer called BetterLifeGoods.com that uses retail profits to help support consumer advocacy programs. He's also a successful software entrepreneur, having founded a well known email marketing software company whose technology currently powers the NaturalNews email newsletters. Adams also serves as the executive director of the Consumer Wellness Center, a non-profit consumer protection group, and practices nature photography, Capoeira, Pilates and organic gardening. Known as the 'Health Ranger,' Adams' personal health statistics and mission statements are located at www.HealthRanger.org

Related Articles

Additional Resources: statin drugs the FDA over-the-counter drugs	Take Action: Support NaturalNews.com Email this article to a friend Share this article on: NewsVine | digg | del.icio.us Permalink to this article: http://www.NaturalNews.com/003229.html Reprinting this article: Non-commercial OK, cite NaturalNews.com with clickable link. <a href = "http://www.NaturalNews.com/003229.html">FDA panel says no to over-the-counter statin drugs; will the recommendation stand?</a>
Receive our Natural Health Newsletter for FREE Subscribe now (it's free!) to win. We randomly choose a subscriber each month to send $100 in eco-home products or a RealGoods.com gift certificate (our choice). Plus, you'll receive FREE news, articles and action alerts from NaturalNews.com editors and join over 800,000 monthly readers who report extraordinary health improvements after becoming a subscriber! Receive breaking news alerts on natural health solutions, renewable energy, the environment, global warming and more. Receive a free instant download of our $29 Secret Sources guide that reveals top sources for little-known health and diet solutions.	Your Email Address: Free Subscription Code: Enter the numbers you see: 100% free of charge. Unsubscribe anytime. Absolutely no spam. We respect your email privacy.
Recommended Special Report: Seven Words that can Change the World by Joseph R. Simonetta Read this special report now... "Seven Words That Can Change the World reveals the astonishing, simple truths that have the power to forever transform our world for the better while freeing our minds from the enslavement of limiting beliefs. This is not a text for the simple-minded; it is a guiding philosophy for the mindful, intelligent few who are wise enough to seek out -- and recognize -- the higher simplicities of truly purposeful living." - Mike Adams, the Health Ranger, editor of NaturalNews.com	More on NaturalNews.com: • Streaming Health Ranger Videos • CounterThink Cartoons • FREE Special Reports • Podcasts